Yonsei University: Breast Neoplasms trials

The registry lists 26 Breast Neoplasms studies with Yonsei University as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 9Phase 3 2Phase 4 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast CancerRecruitingNCT06837792Phase 2
• Preoperative Partial Breast Irradiation in Early-Stage Breast CancerRecruitingNCT06677944Phase 2
• Analgesic Efficacy of Maxigesic in Breast Cancer SurgeryRecruitingNCT06174363Not applicable
• Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast ReconstructionRecruitingNCT05490433Not applicable
• A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)CompletedNCT06207474Not applicable
• Effect of Bra Use During Radiotherapy for Breast Cancer RadiotherapyCompletedNCT06178861Not applicable
• Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2')Status unknownNCT04946227Phase 2
• Elective Internal Mammary Node Irradiation in Women With Node-positive Breast CancerStatus unknownNCT04803266Phase 3
• Talazoparib Maintenance Therapy in Triple-negative Breast CancerStatus unknownNCT04755868Phase 2
• The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast ReconstructionCompletedNCT04440995Not applicable
• Improvement of Patient Experience and Healthcare Providers' Productivity Using Virtual Reality in the Field of Radiation TherapyStatus unknownNCT04141943Not applicable
• Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer PatientsStatus unknownNCT03913234Phase 1/2
• Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast CancerStatus unknownNCT03617341
• Durvalumab (MEDI4736) and Tremelimumab in Hormone Receptor-positive, Hypermutated Metastatic Breast Cancer Identified by Whole Exome SequencingCompletedNCT03608865Phase 2
• Safety and Efficacy of Pegteograstim in Korean Breast Cancer PatientsCompletedNCT03575520Phase 2
• Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast CancerStatus unknownNCT03568981
• Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation TherapyStatus unknownNCT03523078
• Pembrolizumab and Paclitaxel in Hypermutated Breast CancerCompletedNCT03492918Phase 2
• Analgesic Effect to Postoperative Pain After Mastectomy: Ultrasound-guided Serratus Anterior Plane BlockCompletedNCT02483923Not applicable
• Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)Status unknownNCT02441933Phase 3
• Comparison of the Effect of Total Intravenous Anesthesia and Inhalation Anesthesia on Cancer Cell Cytotoxicity, Micrometastasis and Recurrence of Tumor in Patients Undergoing Breast Tumor ResectionTerminatedNCT02089178Not applicable
• Effect of Midazolam Premedication Before Induction on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast Surgery Due to Breast CancerCompletedNCT01945476Not applicable
• An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast CancerCompletedNCT01660542Phase 4
• Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer SurgeryCompletedNCT01548209Not applicable
• Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer PatientsCompletedNCT01169792
• Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00994968Phase 2